Want to see AU:NVU full AI Analyst Report?
Top Page
Nanoveu Ltd.
(Sydney:NVU)
Select Model
Select Model
Rating:42Neutral
Price Target:
AU$0.06
▲(0.00% Upside)
Action:Upgraded
Date:06/17/26
The score is primarily constrained by weak financial performance (deep losses and ongoing cash burn) and bearish technical conditions (below major moving averages with negative MACD). Valuation does not provide support due to loss-making earnings and no dividend yield data.
Positive Factors
Modest leverage
Low debt in 2025 reduces near-term solvency and refinancing pressure, giving management more flexibility to fund commercialization or pursue partnerships. Over a 2–6 month horizon this structural light leverage profile lowers bankruptcy risk and preserves capacity to raise growth capital if needed.
Negative Factors
Persistent cash burn
Consistent negative operating and free cash flow indicates the business cannot self-fund growth and is reliant on external financing. Over months this persistent burn constrains runway, forces dilutive capital raises or credit reliance, and limits ability to invest in scaling or partner commitments.
Read all positive and negative factors
Positive Factors
Negative Factors
Modest leverage
Low debt in 2025 reduces near-term solvency and refinancing pressure, giving management more flexibility to fund commercialization or pursue partnerships. Over a 2–6 month horizon this structural light leverage profile lowers bankruptcy risk and preserves capacity to raise growth capital if needed.
Read all positive factors
Nanoveu Ltd. (NVU) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$68.50M
Dividend YieldN/A
Average Volume (3M)9.28M
Price to Earnings (P/E)―
Beta (1Y)2.36
Revenue GrowthN/A
EPS GrowthN/A
CountryAU
Employees9
SectorTechnology
Sector Strength88
IndustrySoftware - Application
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,087,314,800
10 Day Avg. Volume7,199,231
30 Day Avg. Volume9,283,654
Financial Highlights & Ratios
PEG Ratio-0.19
Price to Book (P/B)5.64
Price to Sales (P/S)233.13
P/FCF Ratio-11.71
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Nanoveu Ltd. Business Overview & Revenue Model
Company Description
Nanoveu Limited, an Australian technology company founded in 2018 and based in Subiaco, focuses on inventing and globally marketing nanotechnology-based solutions for consumer electronics. Its current offerings include Nanoshield, an antiviral pro...
How the Company Makes Money
Nanoveu’s monetisation is primarily tied to commercialising its proprietary coating/film technology through product sales and/or licensing arrangements with distribution and manufacturing partners. Potential revenue streams typically include: (1) ...
Nanoveu Ltd. Financial Statement Overview
Summary
Income Statement
12
Very Negative
Balance Sheet
46
Neutral
Cash Flow
18
Very Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 297.58K | 6.87K | 102.54K | 159.51K | 781.21K |
| Gross Profit | -2.23M | 10.53K | 25.27K | 72.37K | 386.56K |
| EBITDA | -7.45M | -2.73M | -1.98M | -2.45M | -1.97M |
| Net Income | -7.42M | -2.85M | -2.16M | -2.67M | -2.32M |
Balance Sheet | |||||
| Total Assets | 13.55M | 1.32M | 513.00K | 427.33K | 2.75M |
| Cash, Cash Equivalents and Short-Term Investments | 1.81M | 498.30K | 73.07K | 248.14K | 2.01M |
| Total Debt | 341.96K | 126.33K | 225.26K | 300.00K | 986.68K |
| Total Liabilities | 1.46M | 983.58K | 622.40K | 700.75K | 1.17M |
| Stockholders Equity | 12.31M | 374.94K | -109.41K | -273.41K | 1.58M |
Cash Flow | |||||
| Free Cash Flow | -5.92M | -2.10M | -2.01M | -2.82M | -2.04M |
| Operating Cash Flow | -5.85M | -2.10M | -2.01M | -2.82M | -2.04M |
| Investing Cash Flow | -287.31K | -258.66K | 0.00 | 0.00 | 0.00 |
| Financing Cash Flow | 7.44M | 2.53M | 1.83M | 142.12K | 2.91M |
Nanoveu Ltd. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
57 Neutral | AU$46.15M | 76.36 | 1.96% | 2.94% | 3.65% | 22.22% | |
43 Neutral | AU$18.60M | -3.64 | -153.09% | ― | 6.66% | ― | |
42 Neutral | AU$68.50M | -5.80 | -76.07% | ― | ― | ― | |
42 Neutral | AU$25.38M | -5.36 | 190.04% | ― | -42.72% | ― | |
41 Neutral | AU$51.99M | -3.58 | -60.02% | ― | 15.14% | -102.70% | |
32 Underperform | AU$27.07M | -6.08 | -27.05% | ― | 4.41% | 19.30% |
* Technology Sector Average
AU:NVU
Nanoveu Ltd.
0.06
-0.02
-21.25%
AU:3DP
Pointerra
0.03
-0.02
-37.50%
AU:CCG
Comms Group Ltd. (Australia)
0.08
0.03
50.00%
AU:AMX
Aerometrex Ltd.
0.30
0.07
34.09%
AU:VR1
Vection Technologies Ltd.
0.02
-0.02
-40.00%
AU:ICE
iCetana Ltd.
0.03
-0.04
-58.21%
Nanoveu Ltd. Corporate Events
Nanoveu’s EMASS and Bosch Sensortec unveil ultra-low-power edge AI asset tracking design
Jul 22, 2026
Nanoveu’s EMASS subsidiary has teamed up with Bosch Sensortec to create an intelligent asset-tracking reference design built on the ECS-DoT ultra-low-power edge AI platform. The system fuses data from multiple Bosch sensors to analyse moveme...
Nanoveu validates edge-AI drone chip and buys Spinoff Robotics to deepen full-stack strategy
Jul 21, 2026
Nanoveu reported a pivotal June quarter marked by the real-world validation of its ECS-DoT edge AI chip in live drone trials, showing cruise-efficiency gains of up to 27.8% against a standard PX4 autopilot with minimal additional power consumption...
Nanoveu Drone Trials Double Efficiency Gains on Complex Flight Paths
Jul 12, 2026
Nanoveu’s latest live drone trials show its ECS-DoT edge AI system can deliver peak cruise-energy efficiency gains of up to 51.0% at a flight speed of 7 m/s on complex routes, compared with earlier gains of up to 27.8% on simpler paths. The ...
Nanoveu Seeks Trading Halt Ahead of Key Drone Test Results
Jul 8, 2026
Nanoveu Limited has requested an immediate trading halt in its securities on the ASX, as it prepares to release results from the second phase of live drone performance testing for its ECS-DoT system. The halt will remain in place until either the ...
Nanoveu Grants 4 Million Unquoted Performance Rights Under Incentive Scheme
Jul 2, 2026
Nanoveu Limited has issued 4,000,000 unquoted performance rights under its employee incentive scheme, according to a new filing with the Australian Securities Exchange. The rights, which will not be quoted on the ASX, were granted on 2 July 2026 a...
Nanoveu Issues 2.5 Million Employee Incentive Shares Under Escrow
Jul 2, 2026
Nanoveu Limited has applied to the ASX for the quotation of 2,500,000 new fully paid ordinary shares under its Employee Incentive Scheme, with these shares to be issued to staff but excluding directors and key management personnel. The shares, whi...
Nanoveu Issues 6 Million Unquoted Performance Rights
Jul 1, 2026
Nanoveu Limited has notified the market of the issue of 6,000,000 unquoted performance rights under the ASX code NVUAI, effective 2 July 2026. The new securities, previously flagged via an Appendix 3B, are not quoted and are not intended to be quo...
Nanoveu Seeks ASX Quotation for 3 Million New Shares
Jul 1, 2026
Nanoveu Limited has applied for quotation of 3,000,000 ordinary fully paid shares on the Australian Securities Exchange, with the securities to be issued and quoted from July 2, 2026. The application, lodged under ASX Listing Rules via Appendix 2A...
Nanoveu seals Spinoff Robotics deal to fast-track AI-powered drone push
Jul 1, 2026
Nanoveu has completed the 100% acquisition of Singapore-based Spinoff Robotics, securing two commercially validated drone platforms, ALICE and METRON, along with an experienced aerial robotics engineering team. The deal, which includes shares and ...
Nanoveu discloses expiry of director Alfred Chong’s performance rights
Jun 29, 2026
Nanoveu Limited has reported a change in the security holdings of director Alfred Chong, who holds both direct and indirect interests in the company’s ordinary shares. Prior to the change, Chong held 5,888,462 ordinary shares and 700,000 per...
Nanoveu cancels over 1.1 million unvested performance rights
Jun 29, 2026
Nanoveu Ltd. has announced the lapse of 1,177,500 performance rights, classified as NVUAI securities, after the conditions attached to these rights were not met or became incapable of being satisfied. The cessation of these conditional securities ...
Nanoveu director increases stake through approved share placement
Jun 26, 2026
Nanoveu Limited has disclosed changes in the shareholdings of director David Pevcic, who increased both his direct ordinary shareholding and his unlisted options in the company. Following a placement approved by shareholders, Pevcic’s direct...
Nanoveu Issues 5 Million Performance Rights Under Employee Incentive Scheme
Jun 26, 2026
Nanoveu Limited has issued 5,000,000 unquoted performance rights under its employee incentive scheme, as disclosed in an Appendix 3G filing with the ASX. The performance rights, which are not intended to be quoted on the exchange, form part of the...
Nanoveu issues 681,819 unquoted long-dated options
Jun 26, 2026
Nanoveu Ltd. has notified the market of the issue of 681,819 unquoted options, designated NVUAA and carrying an exercise price of $0.15, with an expiry date of 27 January 2029. The options, which were previously flagged in an earlier capital annou...
Nanoveu Seeks ASX Quotation for Additional Ordinary Shares
Jun 26, 2026
Nanoveu Limited has applied to the Australian Securities Exchange for quotation of 1,363,637 new ordinary fully paid shares, with an issue date of June 26, 2026. The additional securities, linked to previously announced transactions, modestly expa...
Nanoveu completes director placement and issues performance rights to bolster AI and 3D growth strategy
Jun 26, 2026
Nanoveu Limited has completed a capital raising approved at its 2026 annual general meeting, issuing 1,363,637 new shares, 681,819 attaching options and 5,000,000 performance rights linked to the board appointment of Mohammed M. Sabry. The company...
Nanoveu Showcases Sub-1mW Bone-Conduction Voice Control for Next-Gen Hearables
Jun 16, 2026
Nanoveu has unveiled a breakthrough in always-on edge AI sensing, demonstrating real-time keyword spotting on its ECS-DoT chip using bone-conduction vibration from the jawbone instead of microphones, operating at under 1 milliwatt. By capturing sp...
Nanoveu Issues 5 Million Unquoted Performance Rights
May 28, 2026
Nanoveu Limited has notified the market of the issue of 5,000,000 unquoted performance rights, recorded under the ASX security code NVUAI. The new securities, which are not intended to be quoted on the ASX, were issued on 28 May 2026 as part of pr...
Nanoveu Shares Suspended as Company Prepares Drone Tech Acquisition Announcement
May 13, 2026
Nanoveu Limited has requested and been granted a voluntary suspension of its shares on the ASX under Listing Rule 17.2, following the expiry of a prior trading halt. The suspension is to remain in place until either the company releases a pending ...
Nanoveu Seeks Trading Halt Ahead of Drone Technology Acquisition
May 10, 2026
Nanoveu Limited has requested a trading halt on its securities on the ASX as it prepares to announce a proposed acquisition aimed at expanding its drone technology capabilities. The halt will remain in place until either the announcement is releas...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.